Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Disodium clodronate"'
Autor:
Gianantonio, Saviola, Lul, Abdi-Ali, Maria Rosaria, Povino, Lorella, Campostrini, Silvano, Sacco, Luca, Dalle Carbonare, Luca Dalle, Carbonare
We evaluated the efficacy and safety of intramuscular clodronate (CLO) for the treatment of active erosive osteoarthritis of the hand (EOA). Forty outpatients treated with anti-inflammatory (NSAIDs) or analgesic drugs since at least 6 months, for at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::658874912673d726894670d5dab0a1a8
http://hdl.handle.net/11562/991509
http://hdl.handle.net/11562/991509
Publikováno v:
Journal of Musculoskeletal Pain. 18:270-276
Background: The paper reports on two cases of fibrodysplasia ossificans progressiva, a genetically determined condition with no pathogenetic treatment. The pathophysiology of the disease is known partially only. Clinically, it is characterized by fla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0778098a11e1b9a1fa288fba611cfa3a
https://doi.org/10.3109/10582452.2010.501300
https://doi.org/10.3109/10582452.2010.501300
Publikováno v:
Pharmaceutical Research. 15:110-115
Purpose. 31P CP/MAS NMR is used to characterize stability and changes in solid state properties of disodium clodronate tetrahydrate upon variable temperature and slow dehydration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d45bea958eb2c01e0f1b93058e8a130f
https://doi.org/10.1023/a:1011965107205
https://doi.org/10.1023/a:1011965107205
Publikováno v:
European journal of haematology. 79(1)
Bisphosphonate therapy has been shown to significantly reduce the incidence of skeletal complications in patients with myeloma. Several recent reports have described osteonecrosis of the jaw (ONJ) associated with bisphosphonates. These reports mainly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93fe5c7b46c4e82319c2cafb7af5410e
https://pubmed.ncbi.nlm.nih.gov/17598839
https://pubmed.ncbi.nlm.nih.gov/17598839
Autor:
Thua Österman, Leena Laurén
Publikováno v:
Pharmacology & Toxicology. 69:369-371
The levels of clodronate in bone and plasma were determined in rats after subcutaneous injection of a mixture of unlabelled and 14C-labelled disodium clodronate as a single dose (25 mg/5 muCi/kg or of 125 mg/25 muCi/kg), and as repeated doses (25 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1babb75ed33c0530ea7a7c87141cfdde
https://doi.org/10.1111/j.1600-0773.1991.tb01313.x
https://doi.org/10.1111/j.1600-0773.1991.tb01313.x
Autor:
Fred Saad
Publikováno v:
Nature Clinical Practice Urology. 4:584-585
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d68dea809678a154c91e13607844a98
https://doi.org/10.1038/ncpuro0911
https://doi.org/10.1038/ncpuro0911
Publikováno v:
International Journal of Oral and Maxillofacial Surgery. 32:574-575
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6e260659b829c6cbaa25706d7e6ee8c
https://doi.org/10.1016/s0901-5027(03)90401-7
https://doi.org/10.1016/s0901-5027(03)90401-7
Autor:
Kate E Morgan, Eric Low
Publikováno v:
Blood. 120:2074-2074
Abstract 2074 Background: Around 75% of myeloma patients have evidence of myeloma bone disease at diagnosis and most develop it at some point. Bisphosphonates - pamidronate, sodium clodronate and zoledronic acid - have revolutionised the treatment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc60f48ed6f779a72c5d4efbed910cb4
https://doi.org/10.1182/blood.v120.21.2074.2074
https://doi.org/10.1182/blood.v120.21.2074.2074
Publikováno v:
Pharmacologytoxicology. 69(5)
The pharmacokinetics of clodronate was studied in rats after single intravenous, intramuscular and subcutaneous doses of a mixture of unlabelled and 14C-labelled disodium clodronate (25 mg/5 muCi/kg). The peak clodronate concentration in plasma was r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e46bcbc32ce06cdce8df14324e03e9
https://pubmed.ncbi.nlm.nih.gov/1839447
https://pubmed.ncbi.nlm.nih.gov/1839447
Publikováno v:
Oncology. 48(1)
28 consecutive patients with multiple osteolytic bone metastases due to various types of cancer were treated with 300 mg/day of sodium clodronate given intravenously as a 3-hour infusion, 16 patients were treated for 10 days and 12 for 20 days. Our f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b40e14b1897caedf1ec7afc0d98e951c
https://pubmed.ncbi.nlm.nih.gov/1824799
https://pubmed.ncbi.nlm.nih.gov/1824799